These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26757512)

  • 21. Novel nonsense mutation of ABHD5 in Dorfman-Chanarin syndrome with unusual findings: a challenge for genotype-phenotype correlation.
    Aggarwal S; Maras JS; Alam S; Khanna R; Gupta SK; Ahuja A
    Eur J Med Genet; 2012 Mar; 55(3):173-7. PubMed ID: 22373837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chanarin-Dorfman Syndrome: A Neutral Lipid Storage Disease With Ichthyosis and Liver Cirrhosis.
    Rajasekaran V; McFarlane J; Purvis D; Prestidge T; Evans H
    J Pediatr Gastroenterol Nutr; 2023 Mar; 76(3):e66. PubMed ID: 36417465
    [No Abstract]   [Full Text] [Related]  

  • 23. From blood smear to lipid disorder: a case report.
    Elitzur S; Yacobovich J; Dgany O; Krasnov T; Rosenbach Y; Tamary H
    J Pediatr Hematol Oncol; 2013 Nov; 35(8):e329-31. PubMed ID: 23042024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chanarin Dorfman syndrome: a case report with novel nonsense mutation.
    Gupta N; Gothwal S; Satpathy AK; Missaglia S; Tavian D; Das P; Timila D; Kabra M
    Gene; 2016 Jan; 575(2 Pt 1):359-62. PubMed ID: 26353074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chanarin-Dorfman syndrome: a novel mutation in a Turkish girl.
    Ünlüsoy-Aksu A; Sarı S; Eğritaş-Gürkan Ö; Dalgıç B
    Turk J Pediatr; 2015; 57(3):300-3. PubMed ID: 26701953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel mutation of ABHD5 gene in a Chanarin Dorfman patient with unusual dermatological findings.
    Eskiocak AH; Missaglia S; Moro L; Durdu M; Tavian D
    Lipids Health Dis; 2019 Dec; 18(1):232. PubMed ID: 31883530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral lipid accumulation in Chanarin-Dorfman Syndrome.
    Huigen MC; van der Graaf M; Morava E; Dassel AC; van Steensel MA; Seyger MM; Wevers RA; Willemsen MA
    Mol Genet Metab; 2015 Jan; 114(1):51-4. PubMed ID: 25468645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dorfman-Chanarin syndrome: case report with multisystem involvement.
    Hassoun M; El ZZ; Noun P; Beani M; Fakhoury H; Mouawad P; Inati A
    Pediatr Ann; 2008 May; 37(5):353-7, 359-60. PubMed ID: 18543546
    [No Abstract]   [Full Text] [Related]  

  • 29. Ichthyosis, cataracts, and motor delay in an infant: A case of Chanarin-Dorfman syndrome.
    Luu Y; Pithadia DJ; Teng J; Khuu P
    Pediatr Dermatol; 2023; 40(5):879-881. PubMed ID: 36709747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early onset of Chanarin-Dorfman syndrome with severe liver involvement in a patient with a complex rearrangement of ABHD5 promoter.
    Missaglia S; Valadares ER; Moro L; Faguntes ED; Quintão Roque R; Giardina B; Tavian D
    BMC Med Genet; 2014 Mar; 15():32. PubMed ID: 24628803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristic scattergram of white blood cells obtained using the Pentra MS CRP hematology analyzer in a patient with neutral lipid storage disease.
    Inaba T; Nomura N; Takahashi M; Ishizuka K; Yoshika K; Yuasa S; Nakanishi M; Fujita N
    Lab Hematol; 2013 Dec; 19(4):22-4. PubMed ID: 24370872
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dorfman-Chanarin syndrome--a neutral lipid storage disease].
    Wollenberg A; Schaller M; Röschinger W; Schirren CG; Wolff H
    Hautarzt; 1997 Oct; 48(10):753-8. PubMed ID: 9441170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chanarin-Dorfman Syndrome: A comprehensive review.
    Cakmak E; Bagci G
    Liver Int; 2021 May; 41(5):905-914. PubMed ID: 33455044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anesthetic management of a patient with Dorfman-Chanarin syndrome.
    Beştaş A; Bolat E; Bayar MK; Erhan OL
    Middle East J Anaesthesiol; 2011 Oct; 21(3):437-40. PubMed ID: 22428507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effect of acitretin in Chanarin-Dorfman syndrome.
    Israeli S; Pessach Y; Sarig O; Goldberg I; Sprecher E
    Clin Exp Dermatol; 2012 Jan; 37(1):31-3. PubMed ID: 21981352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dorfman-Chanarin syndrome: a rare neutral lipid storage disease.
    Mitra S; Samanta M; Sarkar M; Chatterjee S
    Indian J Pathol Microbiol; 2010; 53(4):799-801. PubMed ID: 21045422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chanarin-Dorfman syndrome.
    Demir B; Sen A; Bilik L; Deveci U; Ozercan IH; Cicek D; Dogan Y
    Clin Exp Dermatol; 2017 Aug; 42(6):699-701. PubMed ID: 28636073
    [No Abstract]   [Full Text] [Related]  

  • 38. Two cases of non-alcoholic fatty liver disease caused by biallelic ABHD5 mutations.
    Adant I; Declercq M; Bird M; Bauters M; Boeckx N; Devriendt K; Cassiman D; Witters P
    J Hepatol; 2020 May; 72(5):1030-1032. PubMed ID: 32107051
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and genetic characterization of a Chanarin Dorfman Syndrome patient born to diseased parents.
    Durdu M; Missaglia S; Moro L; Tavian D
    BMC Med Genet; 2018 May; 19(1):88. PubMed ID: 29843625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging mass spectrometry visualizes ceramides and the pathogenesis of dorfman-chanarin syndrome due to ceramide metabolic abnormality in the skin.
    Goto-Inoue N; Hayasaka T; Zaima N; Nakajima K; Holleran WM; Sano S; Uchida Y; Setou M
    PLoS One; 2012; 7(11):e49519. PubMed ID: 23166695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.